Avalo Therapeutics, Inc. (AVTX) vs Geron Corporation (GERN)
Avalo Therapeutics, Inc. and Geron Corporation are both Biotechnology companies. Avalo Therapeutics, Inc. and Geron Corporation are of similar size ($843.1M and $815.9M). Geron Corporation grew revenue faster over the last twelve months: 24.4% against −92.7%. Avalo Therapeutics, Inc. has the higher net margin (0.00% vs −33.1%) and the lower return on invested capital (−118.2% vs −89.9%). Across the 18 metrics below, Geron Corporation leads on 11 and Avalo Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | AVTX | GERN | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.72% | 93.51% | 65.16% |
| Operating margin | 0.00% | (25.31%) | 0.00% |
| Net margin | 0.00% | (33.05%) | 0.00% |
| Free cash flow margin | 0.00% | (56.10%) | 0.00% |
| Return on equity | (36.27%) | (28.28%) | (57.72%) |
| Return on assets | (32.50%) | (12.59%) | (49.22%) |
| Return on invested capital | (118.21%) | (89.85%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack